Factor analysis of sarcoidosis phenotypes at two referral centers in Brazil

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 28, Issue 1, 2011, Pages 34-43

  Rodrigues, Silva C S ^a   Rocha, N A S ^a   Lima, M S ^a   Arakaki, J S O ^a   Coletta, E N A ^a   Ferreira, R G ^a   Gonzaga, L R ^a   Pereira, C A C ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Classification; Interstitial lung diseases; Phenotyping; Sarcoidosis

Indexed keywords

ADULT; AIRWAY OBSTRUCTION; ARTICLE; BRAZIL; CALCIUM METABOLISM; CONTROLLED STUDY; DISEASE SEVERITY; DYSPNEA; FEMALE; FOLLOW UP; HEALTH CENTER; HEART DISEASE; HUMAN; LUNG FIBROSIS; LUNG SARCOIDOSIS; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; PATIENT REFERRAL; PHENOTYPE; PRIORITY JOURNAL; RADIOGRAPHY; RELAPSE; RESPIRATORY AIRFLOW; RETROSPECTIVE STUDY; VITAL CAPACITY; WEIGHT REDUCTION;

BIOPSY; BRAZIL; FACTOR ANALYSIS, STATISTICAL; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; LUNG; MALE; MIDDLE AGED; PHENOTYPE; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; SARCOIDOSIS, PULMONARY; SPIROMETRY; TIME FACTORS; VITAL CAPACITY;

EID: 79960459808     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Grunewald J, Eklund A, Olerup O. Human leukocyte antigen class I alleles and the disease course in sarcoidosis patients. American Journal of Respiratory and Critical Care Medicine 2004; 169 (6): 696-702. (Pubitemid 38338921)
2. Baughman RP, Teirstein AS, Judson MA, et al. Clinical characteristics of patients in a case control study of sarcoidosis. American Journal of Respiratory and Critical Care Medicine 2001; 164 (10 Pt 1): 1885-9. (Pubitemid 33152325)
3. Romer FK. Presentation of sarcoidosis and outcome of pulmonary changes. Danish Medical Bulletin 1982; 29 (1): 27-32. (Pubitemid 12149959)
4. Sato H, Gratters JC, Pantelidis P, et al. HLA-DQB1*0201: a marker for good prognosis in British and Dutch patients with sarcoidosis. American Iournal of Respiratory Cell and Molecular Biology 2002; 27 (4): 406-12.
5. Grunewald J, Eklund A. Sex-specific manifestations of Lofgren's syndrome. American Journal of Respiratory and Critical Care Medicine 2007; 175 (1): 40-4. (Pubitemid 46105307)
6. Wasfi YS, Rose CS, Murphy JR, et al. A new tool to assess sarcoidosis severity. Chest 2006; 129 (5): 1234-45.
7. Neville E, Walker AN, James DG. Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients. The Quarterly Journal of Medicine 1983; 52 (208): 525-33. (Pubitemid 14245588)
8. Prasse A, Katic C, Germann M, Buchwald A, Zissel G, Muller-Quernheim J. Phenotyping sarcoidosis from a pulmonary perspective. American Journal of Respiratory and Critical Care Medicine 2008; 177 (3): 330-6. (Pubitemid 351198377)
9. Viskum K, Vestbo J. Vital prognosis in intrathoracic sarcoidosis with special reference to pulmonary function and radiological stage. Eur Respir J 1993; 6 (3): 349-53. (Pubitemid 23114879)
10. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. American Journal of Respiratory and Critical Care Medicine 1999; 160 (2): 736-55.
11. Akira M, Kozuka T, Inoue Y, Sakatani M. Long-term follow-up CT scan evaluation in patients with pulmonary sarcoidosis. Chest 2005; 127 (1): 185-91. (Pubitemid 41724575)
12. Gottlieb JE, Israel HL, Steiner RM, Triolo J, Patrick H. Outcome in sarcoidosis. The relationship of relapse to corticosteroid therapy. Chest 1997; 111 (3): 623-31.
13. Pietinalho A, Ohmichi M, Lofroos AB, Hiraga Y, Selroos O. The prognosis of pulmonary sarcoidosis in Finland and Hokkaido, Japan. A comparative five-year study of biopsy-proven cases. Sarcoidosis Vasc Diffuse Lung Dis 2000; 17 (2): 158-66.
14. Mana J, Marcoval J. Erythema nodosum. Clinics in Dermatology 2007; 25 (3): 288-94. (Pubitemid 46856830)
15. Shorr AF, Davies DB, Nathan SD. Predicting mortality in patients with sarcoidosis awaiting lung transplantation. Chest 2003; 124 (3): 922-8. (Pubitemid 37123310)
16. Judson MA, Baughman RP, Thompson BW, et al. Two year prognosis of sarcoidosis: the ACCESS experience. Sarcoidosis Vasc Diffuse Lung Dis 2003; 20 (3): 204-11. (Pubitemid 37351542)
17. Sharma OP, Johnson R. Airway obstruction in sarcoidosis. A study of 123 nonsmoking black American patients with sarcoidosis. Chest 1988; 94 (2): 343-6.
18. Handa T, Nagai S, Fushimi Y, et al. Clinical and radiographic indices associated with airflow limitation in patients with sarcoidosis. Chest 2006; 130 (6): 1851-6. (Pubitemid 46033445)
19. Loddenkemper R, Kloppenborg A, Schoenfeld N, Grosser H, Costabel U. Clinical findings in 715 patients with newly detected pulmonary sarcoidosis results of a cooperative study in former West Germany and Switzerland. WATL Study Group. Wissenschaftliche Arbeitsgemeinschaft fur die Therapie von Lungenkrankheitan. Sarcoidosis Vasc Diffuse Lung Dis 1998; 15 (2): 178-82.
20. Mahler DA, Weinberg DH, Wells CK, Feinstein AR. The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest 1984; 85 (6): 751-8.
21. Vandevoorde J, Verbanck S, Gijssels L, et al. Early detection of COPD: a case finding study in general practice. Respiratory Medicine 2007; 101 (3): 525-30. (Pubitemid 46196326)
22. Judson MA, Baughman RP, Teirstein AS, Terrin ML, Yeager H, Jr. Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. ACCESS Research Group. A Case Control Etiologic Study of Sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16 (1): 75-86.
23. Scadding JG. Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years' observation. British Medical Journal 1961; 2 (5261): 1165-72.
24. Miller MR, Hankinson J, Brasasco V, et al. Standardisation of spirometry. Eur Respir J 2005; 26 (2): 319-38.
25. Pereira CAC BS, Simões JG, Pereira FWL, Gerstler JG, Nakatani J. Valores de referência para espirometria em uma amostra da população brasileira adulta. J Pneumologia 1992; 18: 10-22.
26. Portney LG aWM. Foudations of Clinical Research: Applications to Practice. In: River. US, ed. 3rd ed. New Jersey, 2009: 705-15.
27. Norman GR aSD. Biostatistics: the bare essential. In: Decker. B, ed. 2nd. ed. Toronto, 2000:163-77.
28. Kruit A, Gratters JC, Ruven HJ, et al. Transforming growth factorbeta gene polymorphisms in sarcoidosis patients with and without fibrosis. Chest 2006; 129 (6): 1584-91. (Pubitemid 43894990)
29. Teirstein AT, Morgenthau AS. "End-stage" pulmonary fibrosis in sarcoidosis. The Mount Sinai journal of medicine, New York, 2009; 76 (1): 30-6.
30. Reich JM, Johnson RE. Course and prognosis of sarcoidosis in a nonreferral setting. Analysis of 86 patients observed for 10 years. The American Journal of Medicine 1985; 78 (1): 61-7.
31. Hillerdal G, Nou E, Osterman K, Schmekel B. Sarcoidosis: epidemiology and prognosis. A 15-year European study. The American Review of Respiratory Disease 1984; 130 (1): 29-32.
32. Lenner R, Schilero GJ, Padilla ML, Teirstein AS. Sarcoidosis presenting in patients older than 50 years. Sarcoidosis Vasc Diffuse Lung Dis 2002; 19 (2): 143-7.
33. Nagai S, Handa T, Ito Y, Ohta K, Tamaya M, Izumi T. Outcome of sarcoidosis. Clinics in Chest Medicine 2008; 29 (3): 565-74, x.
34. Hunninghake GW, Gilbert S, Pueringer R, et al. Outcome of the treatment for sarcoidosis. American Journal of Respiratory and Critical Care Medicine 1994; 149 (4 Pt 1): 893-8.
35. Vestbo J, Viskum K. Respiratory symptoms at presentation and longterm vital prognosis in patients with pulmonary sarcoidosis. Sarcoidosis 1994; 11 (2): 123-5.
36. Laohaburanakit P, Chan A. Obstructive sarcoidosis. Clinical Reviews in Allergy & Immunology 2003; 25 (2): 115-29.
37. Nishino M, Lee KS, Itoh H, Hatabu H. The spectrum of pulmonary sarcoidosis: variations of high-resolution CT findings and clues for specific diagnosis. European Journal of Radiology; 73 (1): 66-73.
38. Lenique F, Brauner MW, Grenier P, Battesti JP, Loiseau A, Valeyre D. CT assessment of bronchi in sarcoidosis: endoscopic and pathologic correlations. Radiology 1995; 194 (2): 419-23.
39. Nishino M, Kuroki M, Roberts DH, Mori Y, Boiselle PM, Hatabu H. Bronchomalacia in sarcoidosis: evaluation on volumetric expiratory high-resolution CT of the lung. Academic Radiology 2005; 12 (5): 596-601.
40. Hannuksela M, Salo OP, Mustakallio KK. The prognosis of acute untreated sarcoidosis. Annals of Clinical Research 1970; 2 (1): 57-61.
41. Sharma OP. Vitamin D, calcium, and sarcoidosis. Chest 1996; 109 (2): 535-9.
42. Mayock RL, Bertrand P, Morrison CE, Scott JH. Manifestations of Sarcoidosis. Analysis of 145 Patients, with a Review of Nine Series Selected from the Literature. The American Journal of Medicine 1963; 35: 67-89.
43. Morimoto T, Azuma A, Abe S, et al. Epidemiology of sarcoidosis in Japan. Eur Respir J 2008; 31 (2): 372-9.
44. Rossman MD, Kreider ME. Lesson learned from ACCESS (A Case Controlled Etiologic Study of Sarcoidosis). Proc Am Thorac Soc 2007; 4 (5): 453-6.
45. Kreider ME, Christie JD, Thompson B, et al. Relationship of environmental exposures to the clinical phenotype of sarcoidosis. Chest 2005; 128 (1): 207-15.
46. Pietinalho A, Furuya K, Yamaguchi E, Kawakami Y, Selroos O. The angiotensin-converting enzyme DD gene is associated with poor prognosis in Finnish sarcoidosis patients. Eur Respir J 1999; 13 (4): 723-6.
47. Wenzel SE. Asthma: defining of the persistent adult phenotypes. Lancet 2006; 368 (9537): 804-13.